431 related articles for article (PubMed ID: 22682188)
81. Sporotrichoid chromomycosis.
Kawtar I; Salim G; Mariame M; Fatimazahra M; Imane T; Salma B; Imane el H; Mohamed E
Dermatol Online J; 2013 Nov; 19(11):20394. PubMed ID: 24314771
[TBL] [Abstract][Full Text] [Related]
82. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
[TBL] [Abstract][Full Text] [Related]
83. Case Report: Treatment of Chromoblastomycosis with Combinations including Acitretin: A Report of Two Cases.
Belda W; Criado PR; Domingues Passero LF
Am J Trop Med Hyg; 2020 Nov; 103(5):1852-1854. PubMed ID: 32815507
[TBL] [Abstract][Full Text] [Related]
84. An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Arca E; Taştan HB; Akar A; Kurumlu Z; Gür AR
J Dermatolog Treat; 2002 Mar; 13(1):3-9. PubMed ID: 12006131
[TBL] [Abstract][Full Text] [Related]
85. Histopathology and antifungal treatment of experimental murine chromoblastomycosis caused by Cladophialophora carrionii.
Calvo E; Pastor FJ; Salas V; Mayayo E; Capilla J; Guarro J
J Antimicrob Chemother; 2012 Mar; 67(3):666-70. PubMed ID: 22190608
[TBL] [Abstract][Full Text] [Related]
86. Chromoblastomycosis imported from Malta.
Ezughah FI; Orpin S; Finch TM; Colloby PS
Clin Exp Dermatol; 2003 Sep; 28(5):486-7. PubMed ID: 12950332
[TBL] [Abstract][Full Text] [Related]
87. [Management of chromoblastomycosis, a challenge for limited-resource countries such as Madagascar].
Sendrasoa FA; Rakotoarisaona MF; Ranaivo IM; Razanakoto NH; Sata M; Raharolahy O; Andrianarison M; Ratovonjanahary V; Rasamoelina T; Rapelanoro Rabenja F; Ramarozatovo LS
Ann Dermatol Venereol; 2020 May; 147(5):377-382. PubMed ID: 32220474
[TBL] [Abstract][Full Text] [Related]
88. [Generalized chromomycosis caused by Phialophora verrucosa].
Radouane N; Hali F; Khadir K; Soussi M; Ouakadi A; Marouane S; Zamiati S; Benchikhi H
Ann Dermatol Venereol; 2013 Mar; 140(3):197-201. PubMed ID: 23466152
[TBL] [Abstract][Full Text] [Related]
89. A case of relapsed chromoblastomycosis due to Fonsecaea monophora: antifungal susceptibility and phylogenetic analysis.
Daboit TC; Magagnin CM; Heidrich D; Castrillón MR; Mendes SD; Vettorato G; Valente P; Scroferneker ML
Mycopathologia; 2013 Aug; 176(1-2):139-44. PubMed ID: 23645135
[TBL] [Abstract][Full Text] [Related]
90. CHROMOBLASTOMYCOSIS MASQUERADING AS DERMATOPHYTOSIS, WITH THE DESCRIPTION OF A NEW OPPORTUNISTIC SPECIES.
Kampirapap K; Reangchainam S; Ornpaew P; Tresukosol P
Southeast Asian J Trop Med Public Health; 2015 Jan; 46(1):105-9. PubMed ID: 26513911
[TBL] [Abstract][Full Text] [Related]
91. A Case of Chromoblastomycosis Caused by Fonsecaea Pedrosoi and Investigation of the Pathogenic Fungi.
Zhang R; Ran Y; Zhang H; Dai Y; Ran X; Zhang C; Qin W; Xi L
Mycopathologia; 2019 Apr; 184(2):349-352. PubMed ID: 30701405
[No Abstract] [Full Text] [Related]
92. A case of chromoblastomycosis responding to treatment with itraconazole.
Smith CH; Barker JN; Hay RJ
Br J Dermatol; 1993 Apr; 128(4):436-9. PubMed ID: 8388236
[TBL] [Abstract][Full Text] [Related]
93. Successful treatment of chromoblastomycosis due to Fonsecaea pedrosoi by the combination of itraconazole and cryotherapy.
Kullavanijaya P; Rojanavanich V
Int J Dermatol; 1995 Nov; 34(11):804-7. PubMed ID: 8543418
[TBL] [Abstract][Full Text] [Related]
94. Chromoblastomycosis in children and adolescents in the endemic area of the Falcón State, Venezuela.
Pérez-Blanco M; Hernández Valles R; García-Humbría L; Yegres F
Med Mycol; 2006 Aug; 44(5):467-71. PubMed ID: 16882614
[TBL] [Abstract][Full Text] [Related]
95. Synergistic effect of terbinafine and amphotericin B in killing Fonsecaea nubica in vitro and in vivo.
Zhang J; Wu X; Li M; Huang J; Yin S; Huang H; Lu C; Xi L
Rev Inst Med Trop Sao Paulo; 2019 Jun; 61():e31. PubMed ID: 31241660
[TBL] [Abstract][Full Text] [Related]
96. Subcutaneous phaeohyphomycosis of the face presenting as rhinoentomophthoramycosis.
Mahajan VK; Chauhan PS; Mehta KS; Abhinav C; Sharma V; Thakur K
Int J Dermatol; 2013 Sep; 52(9):1105-8. PubMed ID: 23834722
[TBL] [Abstract][Full Text] [Related]
97. Chromoblastomycosis by Cladophialophora carrionii associated with squamous cell carcinoma and review of published reports.
Rojas OC; González GM; Moreno-Treviño M; Salas-Alanis J
Mycopathologia; 2015 Feb; 179(1-2):153-7. PubMed ID: 25344197
[TBL] [Abstract][Full Text] [Related]
98. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
Coelho RA; Joffe LS; Alves GM; Figueiredo-Carvalho MHG; Brito-Santos F; Amaral ACF; Rodrigues ML; Almeida-Paes R
PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
[TBL] [Abstract][Full Text] [Related]
99. Pulse itraconazole 400 mg daily in the treatment of chromoblastomycosis.
Ungpakorn R; Reangchainam S
Clin Exp Dermatol; 2006 Mar; 31(2):245-7. PubMed ID: 16487103
[TBL] [Abstract][Full Text] [Related]
100. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study.
Esterre P; Inzan CK; Ramarcel ER; Andriantsimahavandy A; Ratsioharana M; Pecarrere JL; Roig P
Br J Dermatol; 1996 Jun; 134 Suppl 46():33-6; discussion 40. PubMed ID: 8763467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
